Compugen
CGEN • NASDAQ
Compugen is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eran Ophir, with a market cap of $234.5M.
Market Cap$234.5M
Employees68.0
CEOEran Ophir
CountryIsrael
Healthcare
Biotechnology
Next EarningsMay 18, 2026 · in a monthQ1 2026
Financials
CGE
Compugen FAQ
Common questions about Compugen
Compugen is scheduled to report earnings for Q1 2026 on May 18, 2026. Analysts estimate revenue of $1.8M.
Compugen has approximately 68 employees.